Contribution to development and distribution of useful and safe medical products
Along with the recent advancement in technology and globalization of corporate activities, the significance of protection of intellectual property is increasing.
Furthermore, drug development requires a long time and an enormous amount of cost in research and development. CMIC's Intellectual Property Development (IPD) services include acquisition of intellectual property rights, development and sales of products after intellectual property right acquisition and assignment of authority for sales to third parties, as necessary. IPD targets faster distribution of safe drugs meeting the needs of clinical sites.
Provides higher added values
- Knowledge and know-how accumulated over years as a leading CRO
- Making full use of knowledge and expertise acquired through its longstanding business, CMIC provides highly reliable data on medical products effectively and quickly.
- The Scientific Advisor
- To incorporate professional advice and proposals, CMIC has established the Scientific Advisor. All operations reflect opinions from specialists.
- The latest knowledge and information
- By providing wide-ranging services, CMIC can always access the latest knowledge and information.
- L-FABP (Diagnostic application of L-FABP to predict kidney disease progression)
- PTX-3 (Diagnostic marker for arterial sclerosis)
